Cancer Family
Trophoblastic Tumor
CI-CAN-00000376Explore in graph →
Non-malignant12 active trials1 approved drugs
Loading cancer entity…
Cancer Family
CI-CAN-00000376Explore in graph →
Clinical trials
82 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05405192 | Dostarlimab in Chemoresistant Gestational Trophoblastic Neoplasia | withdrawn | Phase 2 | 0 | University of MiamiOTHER | 1 | Feb 28, 2023 | clinicaltrials |
Data updated 22 days agoSource updated Feb 28, 2023source: clinicaltrials